title: The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population.
authors.affiliation: Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP, Brazil.
authors.forename: Débora
authors.initials: D
authors.lastname: Levy
authors.forename: Marcelo
authors.initials: M
authors.lastname: Bellesso
authors.forename: Pamela
authors.initials: P
authors.lastname: Oliveira-Souza
authors.forename: Felipe V
authors.initials: FV
authors.lastname: Maciel
authors.forename: Juliana
authors.initials: J
authors.lastname: Pereira
authors.forename: Sérgio P
authors.initials: SP
authors.lastname: Bydlowski
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005838:Genotype; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011241:Prednisone / Q000008:administration & dosage; D017452:Receptors, IgG / Q000235:genetics*; D000069283:Rituximab; D016019:Survival Analysis; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C080568:Fc gamma receptor IIA; D017452:Receptors, IgG; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone